Insider Profile
Chapnik, Jason
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Apr 01, 2026
Most Recent Trade
44
Credibility
Score
65%
Hit Rate
+9.6%
Avg 90d Return
+9.8%
Median 90d Return
31
Evaluated Trades
+74.0%
Best Trade
-41.9%
Worst Trade
Hit rate and returns are based on 31 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. This insider has a solid track record of profitable timing.
Cross-Company Track Record
80%
Hit Rate · 90d
+26.8%
Median Alpha · 90d
5
Closed Buys Evaluated
80%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
cluster buyer high frequency size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 5 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Apr 01, 2026 $DCBO
Docebo
— Comp. Grant Buy 2,070 $24.06 $50K 43
Mar 11, 2026 $DCBO
Docebo
— Buyback Buy 372,612 $20.40 $7.6M 43
Mar 11, 2026 $DCBO
Docebo
— Buyback Buy 372,612 $20.40 $7.6M 43
Mar 11, 2026 $DCBO
Docebo
— Buyback Buy 372,613 $20.40 $7.6M 43
Mar 06, 2026 $DCBO
Docebo
— Ownership Chg Sell 12,655,249 — — 43
Mar 06, 2026 $DCBO
Docebo
— Ownership Chg Buy 12,655,249 — — 43
Feb 27, 2026 $DCBO
Docebo
— Ownership Chg Buy 3,630,715 — — 43
Feb 27, 2026 $DCBO
Docebo
— Ownership Chg Sell 3,630,715 — — 43
Jan 02, 2026 $DCBO
Docebo
— Comp. Grant Buy 1,637 $30.43 $50K 43
Nov 27, 2025 $DCBO
Docebo
— Open Market Sell 3,630,715 $18.77 $68.1M 43
Oct 01, 2025 $DCBO
Docebo
— Comp. Grant Buy 1,271 $39.16 $50K 43
Jul 02, 2025 $DCBO
Docebo
— Comp. Grant Buy 775 $38.05 $29K 43
Jul 02, 2025 $DCBO
Docebo
— Comp. Grant Buy 3,941 $38.05 $150K 43
Apr 01, 2025 $DCBO
Docebo
— Comp. Grant Buy 681 $43.29 $29K 43
Jan 02, 2025 $DCBO
Docebo
— Comp. Grant Buy 450 $65.52 $29K 43
Oct 01, 2024 $DCBO
Docebo
— Comp. Grant Buy 490 $60.14 $29K 43
Jul 01, 2024 $DCBO
Docebo
— Comp. Grant Buy 500 $51.95 $26K 43
Jul 01, 2024 $DCBO
Docebo
— Comp. Grant Buy 3,893 $51.95 $202K 43
Apr 01, 2024 $DCBO
Docebo
— Comp. Grant Buy 381 $68.04 $26K 43
Jan 02, 2024 $DCBO
Docebo
— Comp. Grant Buy 388 $66.82 $26K 43
Dec 29, 2023 $DCBO
Docebo
— Open Market Sell 934,669 $55.00 $51.4M 43
Sep 30, 2023 $DCBO
Docebo
— Comp. Grant Buy 493 $52.47 $26K 43
Jul 01, 2023 $DCBO
Docebo
— Comp. Grant Buy 516 $50.54 $26K 43
Jul 01, 2023 $DCBO
Docebo
— Comp. Grant Buy 3,703 $50.54 $187K 43
Apr 03, 2023 $DCBO
Docebo
— Comp. Grant Buy 489 $53.15 $26K 43
Jan 03, 2023 $DCBO
Docebo
— Comp. Grant Buy 596 $43.94 $26K 43
Oct 03, 2022 $DCBO
Docebo
— Comp. Grant Buy 703 $37.21 $26K 43
Jul 04, 2022 $DCBO
Docebo
— Comp. Grant Buy 3,690 $38.97 $144K 43
Jul 04, 2022 $DCBO
Docebo
— Comp. Grant Buy 320 $38.97 $12K 43
Apr 01, 2022 $DCBO
Docebo
— Comp. Grant Buy 197 $63.29 $12K 43
Jan 04, 2022 $DCBO
Docebo
— Comp. Grant Buy 143 $86.93 $12K 43
Jun 18, 2021 $DCBO
Docebo
— Comp. Grant Buy 2,167 $66.91 $145K 43
Apr 01, 2021 $DCBO
Docebo
— Comp. Grant Buy 193 $51.63 $10K 43
Jan 26, 2021 $DCBO
Docebo
— Open Market Buy 2,083,754 $49.67 $103.5M 43
Jan 01, 2021 $DCBO
Docebo
— Comp. Grant Buy 129 $77.47 $10K 43
Oct 01, 2020 $DCBO
Docebo
— Comp. Grant Buy 219 $45.53 $10K 43
Sep 03, 2020 $DCBO
Docebo
— Open Market Buy 22,426 $50.00 $1.1M 43
Sep 03, 2020 $DCBO
Docebo
— Open Market Buy 202,574 $50.00 $10.1M 43
Aug 27, 2020 $DCBO
Docebo
— Open Market Buy 740,126 $50.00 $37.0M 43
Aug 27, 2020 $DCBO
Docebo
— Open Market Buy 60,000 $50.00 $3.0M 43
Jul 22, 2020 $DCBO
Docebo
— Comp. Grant Buy 2,829 $38.87 $110K 43
Jul 01, 2020 $DCBO
Docebo
— Comp. Grant Buy 286 $34.89 $10K 43
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.